Synapse - Works

Results (2639)

A prospective multicenter study of the Bruton's tyrosine kinase inhibitor ibrutinib in patients with relapsed or refractory Waldenstrom's macroglobulinemia

Meeting Abstract

Treon, S. P.; Tripsas, C. K.; Yang, G.; Cao, Y.; Xu, L.; Hunter, Z.; Cropper, S. J.; Mostyn, P.; Meid, K.; Warren, D.; more...
Blood (2013)

Fulltext@MSK | Save

Microenvironment assessment, disease characteristics and prognosis In HIV-associated (HIV-cHL) and HIV-negative classical Hodgkin lymphoma: The influence of Epstein Barr virus (EBV)

Meeting Abstract

Rubinstein, P. G.; Sreenivasappa, S.; Messinger, M.; Petrich, A. M.; Moreira, J.; Bryan, L. J.; Angelova, V.; Gupta, S.; Noy, A.; Sumpter, I.; more...
Blood (2013)

Fulltext@MSK | Save

Next-generation sequencing suggests complex, heterogeneous pathogenesis in peripheral T-cell lymphoma unspecified

Meeting Abstract

Schatz, J. H.; Horwitz, S. M.; Lunning, M. A.; Dolgalev, I.; Huberman, K.; Heguy, A.; Viale, A.; Socci, N. D.; Pirun, M.; Teruya-Feldstein, J.; more...
Blood (2013)

Fulltext@MSK | Save

Phase II trial of bortezomib in combination with fractionated cyclophosphamide and rituximab (BCR) for relapsed/refractory mantle cell lymphoma (MCL)

Meeting Abstract

Romaguera, J. E.; Fanale, M. A.; Samaniego, F.; Fayad, L. E.; Hagemeister, F. B.; McLaughlin, P.; Rodriguez, M. A.; Weaver, P.; Hartig, K.; Badillo, M.; more...
Blood (2013)

Fulltext@MSK | Save

FDG-PET adapted sequential therapy with brentuximab vedotin and augmented ICE followed by autologous stem cell transplant for relapsed and refractory Hodgkin lymphoma

Meeting Abstract

Moskowitz, A.; Schoder, H.; Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Keskinyan, V. S.; McCall, S.; Noy, A.; Palomba, M. L.; more...
Blood (2013)

Fulltext@MSK | Save

A proposed prognostic model for overall survival in the oldest old (>80 years old) follicular lymphoma patients

Meeting Abstract

Nabhan, C.; Byrtek, M.; Dawson, K. L.; Zhou, X.; Link, B. K.; Friedberg, J. W.; Zelenetz, A. D.; Cerhan, J. R.; Flowers, C. R.
Blood (2013)

Fulltext@MSK | Save

Identification of actionable genomic alterations in hematologic malignancies by a clinical next generation sequencing-based assay

Meeting Abstract

Lipson, D.; Nahas, M. K.; Otto, G. A.; Yelensky, R.; Abdel-Wahab, O.; Wang, K.; He, J.; Intlekofer, A. M.; Rampal, R. K.; Brennan, T. A.; more...
Blood (2013)

Fulltext@MSK | Save

Excellent outcomes for limited-stage diffuse large B-cell lymphoma in the rituximab era: A retrospective analysis from Memorial Sloan-Kettering Cancer Center

Meeting Abstract

Kumar, A.; Maragulia, J. C.; Lunning, M. A.; Moskowitz, C. H.; Zelenetz, A. D.
Blood (2013)

Fulltext@MSK | Save

Profiling genomic alterations of diffuse large B-cell lymphoma (DLBCL) at diagnosis, relapse, and transformation, using a novel clinical diagnostic targeted sequencing platform

Meeting Abstract

Intlekofer, A. M.; Sheshan, V. E.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; van den Brink, M. R. M.; Knapp, K. M.; more...
Blood (2013)

Fulltext@MSK | Save

Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo) substituted for non-liposomal vincristine in CHOP with or without rituximab for patients with untreated aggressive non-Hodgkin's lymphomas

Meeting Abstract

Hagemeister, F. B.; Rodriguez, M. A.; Deitcher, S. R.; Younes, A.; Fayad, L.; Goy, A.; Dang, N. H.; Forman, A.; McLaughlin, P.; Pro, B.; more...
Blood (2013)

Fulltext@MSK | Save